BETA DRUGS
Back to Balance Sheet
|
BETA DRUGS Last 5 Year Total Debt History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Debt | ₹138 Cr | ₹15 Cr | ₹20 Cr | ₹21 Cr | ₹17 Cr |
What is the latest Total Debt ratio of BETA DRUGS ?
| Year | Total Debt |
|---|---|
| Mar2025 | ₹138 Cr |
| Mar2024 | ₹15 Cr |
| Mar2023 | ₹20 Cr |
| Mar2022 | ₹21 Cr |
| Mar2021 | ₹17 Cr |
How is Total Debt of BETA DRUGS Trending?
| Years | Total Debt | % Change | |
|---|---|---|---|
| Mar2025 | ₹138 Cr | 838.45 | |
| Mar2024 | ₹15 Cr | -27.65 | |
| Mar2023 | ₹20 Cr | -1.31 | |
| Mar2022 | ₹21 Cr | 17.97 | |
| Mar2021 | ₹17 Cr | - | |
Compare Total Debt of peers of BETA DRUGS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| BETA DRUGS | ₹2,323.7 Cr | 1.9% | -8.5% | 18.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹444,597.0 Cr | 1% | -3.3% | 13.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹255,195.0 Cr | 2.6% | 10.8% | 57.3% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹187,712.0 Cr | 2.7% | 0.3% | 39.6% | Stock Analytics | |
| CIPLA | ₹113,423.0 Cr | 2.4% | -1.1% | -12.6% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,195.0 Cr | 2.5% | 0.8% | -8.5% | Stock Analytics | |
BETA DRUGS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| BETA DRUGS | 1.9% |
-8.5% |
18.5% |
| SENSEX | -1% |
-4.9% |
-11% |
You may also like the below Video Courses